Latest developments and challenges in the diagnosis of human West Nile virus infection
West Nile virus (WNV) is a mosquito-borne flavivirus responsible for an increasing number of human outbreaks of neuroinvasive disease in Europe and in North America. Notwithstanding the improvements in the knowledge of virus epidemiology and clinical course of infection and the development of new laboratory tests, the diagnosis of WNV infection remains challenging and many cases still remain unrecognized. WNV genome diversity, transient viremia with low viral load and cross-reactivity with other flaviviruses of the antibodies induced by WNV infection are important hurdles that require the diagnosis to be performed by experienced laboratories. Herein, we present and discuss the novel findings on the molecular epidemiology and clinical features of WNV infection in humans with special focus on Europe, the performance of diagnostic tests and the novel methods that have been developed for the diagnosis of WNV infection. A view on how the field might evolve in the future is also presented.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2015 |
|---|---|
| Erschienen: |
2015 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
|---|---|
| Enthalten in: |
Expert review of anti-infective therapy - 13(2015), 3 vom: 02. März, Seite 327-42 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Barzon, Luisa [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antibodies, Viral |
|---|
| Anmerkungen: |
Date Completed 19.10.2015 Date Revised 30.03.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1586/14787210.2015.1007044 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM245849831 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM245849831 | ||
| 003 | DE-627 | ||
| 005 | 20231224141756.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1586/14787210.2015.1007044 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0819.xml |
| 035 | |a (DE-627)NLM245849831 | ||
| 035 | |a (NLM)25641365 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Barzon, Luisa |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Latest developments and challenges in the diagnosis of human West Nile virus infection |
| 264 | 1 | |c 2015 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.10.2015 | ||
| 500 | |a Date Revised 30.03.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a West Nile virus (WNV) is a mosquito-borne flavivirus responsible for an increasing number of human outbreaks of neuroinvasive disease in Europe and in North America. Notwithstanding the improvements in the knowledge of virus epidemiology and clinical course of infection and the development of new laboratory tests, the diagnosis of WNV infection remains challenging and many cases still remain unrecognized. WNV genome diversity, transient viremia with low viral load and cross-reactivity with other flaviviruses of the antibodies induced by WNV infection are important hurdles that require the diagnosis to be performed by experienced laboratories. Herein, we present and discuss the novel findings on the molecular epidemiology and clinical features of WNV infection in humans with special focus on Europe, the performance of diagnostic tests and the novel methods that have been developed for the diagnosis of WNV infection. A view on how the field might evolve in the future is also presented | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a West Nile virus | |
| 650 | 4 | |a blood | |
| 650 | 4 | |a diagnosis | |
| 650 | 4 | |a human | |
| 650 | 4 | |a molecular test | |
| 650 | 4 | |a neutralization test | |
| 650 | 4 | |a serology test | |
| 650 | 4 | |a serum | |
| 650 | 4 | |a test performance | |
| 650 | 4 | |a urine | |
| 650 | 7 | |a Antibodies, Viral |2 NLM | |
| 700 | 1 | |a Pacenti, Monia |e verfasserin |4 aut | |
| 700 | 1 | |a Ulbert, Sebastian |e verfasserin |4 aut | |
| 700 | 1 | |a Palù, Giorgio |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Expert review of anti-infective therapy |d 2003 |g 13(2015), 3 vom: 02. März, Seite 327-42 |w (DE-627)NLM151540101 |x 1744-8336 |7 nnns |
| 773 | 1 | 8 | |g volume:13 |g year:2015 |g number:3 |g day:02 |g month:03 |g pages:327-42 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1586/14787210.2015.1007044 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 13 |j 2015 |e 3 |b 02 |c 03 |h 327-42 | ||